MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 88.4% in June

MariMed Inc. (OTCMKTS:MRMD) was the target of a large drop in short interest in June. As of June 30th, there was short interest totaling 1,866 shares, a drop of 88.4% from the June 15th total of 16,030 shares. Based on an average trading volume of 668,174 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are short sold.

MariMed Stock Up 0.3%

MRMD traded up $0.00 during midday trading on Friday, reaching $0.07. 101,528 shares of the company were exchanged, compared to its average volume of 286,926. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. The company’s fifty day moving average price is $0.07 and its 200 day moving average price is $0.08. The company has a market cap of $27.15 million, a price-to-earnings ratio of -2.27 and a beta of 1.32. MariMed has a one year low of $0.06 and a one year high of $0.23.

MariMed (OTCMKTS:MRMD) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.The firm had revenue of $39.48 million during the quarter, compared to the consensus estimate of $38.75 million. As a group, analysts expect that MariMed will post -0.04 EPS for the current year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.